Position in BIIB
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$69,273,588
+$16,137,222 QoQ
Shares Held
320,622
+10.6% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#56
of 1,036 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swedbank AB holds $5,796,975,204 across 10 Drug Manufacturers - General names. BIIB ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,781,310 | $2,136,556,831 | |
| 2 | JNJ |
Johnson & Johnson
|
3,624,513 | $920,517,565 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,360,649 | $817,343,396 | |
| 4 | ABBV |
AbbVie Inc.
|
2,634,628 | $662,977,789 | |
| 5 | AZN |
Astrazeneca PLC
|
2,241,677 | $425,066,792 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,903,177 | $240,447,381 | |
| 7 | AMGN |
Amgen Inc
|
517,466 | $187,384,787 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,043,205 | $175,349,471 |
All Filings in BIIB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,273,588 | 320,622 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $53,136,366 | 289,840 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $40,760,866 | 231,609 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $32,560,054 | 232,439 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $26,840,968 | 213,719 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $28,144,161 | 184,045 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $35,861,950 | 185,008 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $23,188,258 | 100,027 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $22,939,366 | 106,383 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $27,469,987 | 106,156 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $28,696,194 | 111,654 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $35,472,940 | 124,532 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $34,789,059 | 125,127 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $33,784,793 | 122,002 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $36,330,690 | 136,070 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $28,787,150 | 141,155 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $38,356,367 | 182,129 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $45,699,001 | 190,476 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $59,672,402 | 210,864 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $72,121,114 | 208,280 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $67,361,561 | 240,792 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||